Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN ), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations inLatin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"),which trades on the New York Stock Exchange.
- TORONTO, July 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN ), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations inLatin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"),which trades on the New York Stock Exchange.
- "We are pleased to be included in The Cannabis ETF index which increases our exposure to U.S. investors, and provides an important opportunity to articulate our vision as a global cannabis company based in Latin America."
- Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.
- View original content to download multimedia: http://www.prnewswire.com/news-releases/khiron-life-sciences-added-to-ny...
SOURCE Khiron Life Sciences Corp.